Latest news
Piper Sandler Maintains Lexicon Pharmaceuticals(LXRX.US) With Buy Rating, Maintains Target Price $6 - MoomooMoomoo · Sat, 08 Aug 2026 06:51:06 GMTLexicon Pharmaceuticals (NASDAQ:LXRX) Announces Earnings Results, Misses Estimates By $0.01 EPS - MarketBeatMarketBeat · Sat, 08 Aug 2026 03:08:57 GMTWhy Lexicon Pharmaceuticals (LXRX) Is Up 6.9% After Q2 Revenue Collapse And New Shelf Filings - Yahoo FinanceYahoo Finance · Sat, 08 Aug 2026 00:15:00 GMTLXRX Aug 2026 5.000 put (LXRX260821P00005000) stock historical prices and data - Yahoo Finance AustraliaYahoo Finance Australia · Fri, 07 Aug 2026 18:39:51 GMTLXRX Aug 2026 5.000 put (LXRX260821P00005000) Stock Historical Prices & Data - Yahoo! Finance CanadaYahoo! Finance Canada · Fri, 07 Aug 2026 13:33:29 GMTLexicon Pharmaceuticals (LXRX) Stockholders Plan to Sell 1.26M S - GuruFocusGuruFocus · Fri, 07 Aug 2026 09:31:47 GMTLXRX S-3 & SEC Filings - Yahoo FinanceYahoo Finance · Fri, 07 Aug 2026 08:14:03 GMTLXRX SWOT Analysis: Financial Challenges and Growth Potential Re - GuruFocusGuruFocus · Fri, 07 Aug 2026 04:47:01 GMT